Benzinga’s Top Ratings Upgrades, Downgrades For December 12, 2022
Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers…
Wolfe Research Upgrades Southern to Outperform, Announces $76 Price Target
Wolfe Research analyst Steve Fleishman upgrades Southern (NYSE:SO) from Peer Perform to Outperform and announces $76 price target.
Goldman Sachs Upgrades Tapestry to Buy, Raises Price Target to $44
Goldman Sachs analyst Brooke Roach upgrades Tapestry (NYSE:TPR) from Neutral to Buy and raises the price target from $37 to $44.
Loop Capital Upgrades Acadia Healthcare Co to Buy, Announces $95 Price Target
Loop Capital analyst Joseph France upgrades Acadia Healthcare Co (NASDAQ:ACHC) from Hold to Buy and announces $95 price target.
Citigroup Upgrades Bio-Techne to Buy, Raises Price Target to $100
Citigroup analyst Patrick Donnelly upgrades Bio-Techne (NASDAQ:TECH) from Neutral to Buy and raises the price target from $81.25 to $100.
Citigroup Upgrades QuidelOrtho to Buy, Raises Price Target to $125
Citigroup analyst Patrick Donnelly upgrades QuidelOrtho (NASDAQ:QDEL) from Neutral to Buy and raises the price target from $90 to $125.
Deutsche Bank Upgrades Lam Research to Buy, Raises Price Target to $520
Deutsche Bank analyst Sidney Ho upgrades Lam Research (NASDAQ:LRCX) from Hold to Buy and raises the price target from $400 to $520.
Morgan Stanley Upgrades CAE to Overweight
Morgan Stanley analyst Kristine Liwag upgrades CAE (NYSE:CAE) from Equal-Weight to Overweight.
Citigroup Upgrades PerkinElmer to Buy, Announces $170 Price Target
Citigroup analyst Patrick Donnelly upgrades PerkinElmer (NYSE:PKI) from Neutral to Buy and announces $170 price target.
JP Morgan Upgrades Monday.Com to Overweight, Raises Price Target to $140
JP Morgan analyst Pinjalim Bora upgrades Monday.Com (NASDAQ:MNDY) from Neutral to Overweight and raises the price target from $130 to $140.